Hotel Le Méridien Versailles, Montreal
Dr. Lisa Hartling, Dr. Sharon Straus, Ms. Michele Boileau-Falardeau, Dr. David Moher
Dr. Tonelli welcomed the group to Montreal and thanked them for their attendance. He noted that there are a few new faces amongst the group and asked that all participants introduce themselves. He noted that the agenda had undergone recent updates and asked if there were any concerns or further changes to be made. None were noted.
Dr. Wilson and Ms. Pillay gave a presentation to the group on issues currently faced by the working group and noted that approval of evidence was needed prior to external review.
Ms. Jaramillo led a verbal update on the progress of the working group so far. Ms. Jaramillo pointed that the internal Infectious Disease team within PHAC may already be working on this topic, so contact will be made with them to determine if this is the case, so as to not duplicate efforts.
Dr. Bashir provided a presentation for the group highlighting the tools, endorsements and media strategies currently in process.
Dr. Thombs gave a short update on the progress of the guideline release and noted that it has now been published in CMAJ.
Ms. Sayal provided the group with an update on the work of the working group. She highlighted the progress of the EMR plug-in for the Breast Cancer screening guideline in OSCAR, which included a live demonstration of the plug-in.
Dr. Groulx updated the group on the progression of the guideline, giving a refresher on the background of Esophageal Adenocarcinoma (EAC), the analytic framework and the Key Questions being used. He also highlighted the outcome rankings for screening and the Key Question on the treatment of Barrett’s.
Dr. Thombs gave a verbal on the progress of this guideline and noted that a grant application has been planned for submission to CIHR.
The acting Director General of the Centre for Chronic Disease Prevention, Gerry Gallagher, provided the group with an update of the Global Health and Guidelines Division via teleconference. Her presentation covered some staffing changes among the group.
Ms. Jaramillo gave a brief verbal update on behalf of Dr. Singh and noted that the guideline has been sent for review.
Dr. Klarenbach provided an update on the progress of the working group. His presentation gave a reminder of the analytic framework and key questions, a status update and looked at the current protocol and comments received from content experts.
Ms. Jaramillo gave a verbal update on the Postnatal Depression working group. Dr. Lang will Chair the working group, with Dr. LeBlanc and Dr. Moore also joining the group.
Dr. Lewin provided a summary of the scoping exercise for the update of this guideline, previously released in 2012. Her presentation gave background on the previous guideline and a refresher of the recommendations.
Ms. Jaramillo gave a presentation updating the group on the current timelines for the guidelines in progress. She thanked the team for all of their hard work and effort, because of this, we are on track to deliver on all commitments.
Dr. Moore gave a presentation to the group giving a high level summary of the evidence to decision framework.
Ms. Jaramillo gave a brief update to inform the group that work on the Hepatitis C guideline will be completed then work will begin on the Thyroid guideline, with the aim to complete this fiscal year.
Dr. Tonelli led discussion on the results obtained from the survey presented that asked, through a number of questions, which journal the group felt would be best suited for CTFPHC guidance.
Ms. Jaramillo delivered the presentation made up of methods completed, in progress and on hold.
Ms. Buckland gave a verbal update to the group on patient preferences phase 2. Ms. Jaramillo presented and Dr. Pottie joined the group via teleconference to discuss the FACE survey.
Ms. Jaramillo asked Task Force members to complete a quick survey on the instructions for the FACE survey.
Dr. Doull provided members with a background on the topics selection process and lessons learned throughout.
Ms. Jaramillo gave a presentation to the group and thanked the ERSC’s for all of their hard work. Her presentation covered the objectives of the scoping exercise and how proposed changes will affect the process.
Dr. Grad began his presentation by thanking the working group for getting this guideline to the finish line. He highlighted the recommendation and discussion was focused on a change to the cost of the drug to treat Hepatitis C.
Dr. Thombs provided the group with an update of the working group and raised the question of whether there is a need to develop a new guideline, reaffirm the existing or adapt the USPSTF guideline.
Dr. Tonelli thanked the group for their attendance and once again welcomed new members to the team. Special thanks were given to Ms. Borne and Ms. Priel for organizing another successful meeting. Members were asked to submit expense claims as soon as possible, before year end (March 31st). Doodle poll results for 2018 will be sent out.